Four rationales indicate that the cancer cell eradicating effects of TH588 alone or in dual-targeting approaches are attributed to an TH588-mediated increase in apoptosis and PI3K-Akt-mTOR pathway downregulation but not oxidative stress:. This evidence concerns the gene AKT1 and cancer.